Choi, Eugene
Shin, Jinho
Ryu, Min-Hee
Kim, Hyung-Don
Park, Young Soo
Article History
Received: 15 April 2024
Accepted: 23 July 2024
First Online: 31 July 2024
Competing interests
: M-H.R. received honoraria from DAEHWA Pharmaceutical, Bristol Myers Squibb, Lilly, Ono Pharmaceutical, MSD, Taiho Pharmaceutical, Novartis, Daiichi Sankyo and AstraZeneca, and served as a consultant for DAEHWA Pharmaceutical, Bristol Myers Squibb, Lilly and Ono Pharmaceutical. H-D.K. received honoraria from AstraZeneca, Bristol Myers Squibb, Ono Pharmaceuticals, Boryung Pharmaceuticals, and Boostimmune; and served as a consultant for Mustbio. E.C., J.S, and Y.S.P. declare no competing interests.